Antifungal use
Use of antifungals in PHO units before and after PHIG intervention is
shown in Table 5 . Overall, 47.4% of patients before and 46.9%
after the intervention received at least one antifungal
(p =0.893). Almost all patients treated in the BMT unit were
receiving at least one antifungal at the time of data collection. Almost
two thirds of children treated in units located in general hospitals
were receiving at least one antifungal compared to approximately one
fourth of patients treated in units located in pediatric hospitals. In
unit 6, antifungal use significantly increased after intervention
(p =0.044). Overall, use of at least one antifungal was
significantly more common in PHO units located in general versus
pediatric hospitals before the intervention (66% compared to 40.9%,p =0.001) and remained so after the intervention (73% compared to
36.2%, p =0.001).